标题
Aberrant histone modifications induced by mutant ASXL1 in myeloid neoplasms
作者
关键词
ASXL1, Histone modifications, H2AK119ub, BAP1, Myeloid neoplasms
出版物
INTERNATIONAL JOURNAL OF HEMATOLOGY
Volume -, Issue -, Pages -
出版商
Springer Nature
发表日期
2018-12-05
DOI
10.1007/s12185-018-2563-7
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Expression of mutant Asxl1 perturbs hematopoiesis and promotes susceptibility to leukemic transformation
- (2018) Reina Nagase et al. JOURNAL OF EXPERIMENTAL MEDICINE
- A novel ASXL1–OGT axis plays roles in H3K4 methylation and tumor suppression in myeloid malignancies
- (2018) Daichi Inoue et al. LEUKEMIA
- Reduced BAP1 activity prevents ASXL1 truncation-driven myeloid malignancy in vivo
- (2018) Ying Guo et al. LEUKEMIA
- Modeling ASXL1 mutation revealed impaired hematopoiesis caused by derepression of p16Ink4a through aberrant PRC1-mediated histone modification
- (2018) Masahiro Uni et al. LEUKEMIA
- Mutant ASXL1 cooperates with BAP1 to promote myeloid leukaemogenesis
- (2018) Shuhei Asada et al. Nature Communications
- Bcor insufficiency promotes initiation and progression of myelodysplastic syndrome
- (2018) Shiro Tara et al. BLOOD
- ASXL1 and SETBP1 mutations promote leukaemogenesis by repressing TGFβ pathway genes through histone deacetylation
- (2018) Makoto Saika et al. Scientific Reports
- Monoubiquitination of ASXLs controls the deubiquitinase activity of the tumor suppressor BAP1
- (2018) Salima Daou et al. Nature Communications
- The distinct biological implications of Asxl1 mutation and its roles in leukemogenesis revealed by a knock-in mouse model
- (2017) Yueh-Chwen Hsu et al. Journal of Hematology & Oncology
- Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease
- (2017) Siddhartha Jaiswal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Asxl1 deficiency in embryonic fibroblasts leads to cellular senescence via impairment of the AKT-E2F pathway and Ezh2 inactivation
- (2017) Hye Sook Youn et al. Scientific Reports
- Truncation mutants of ASXL1 observed in myeloid malignancies are expressed at detectable protein levels
- (2016) Daichi Inoue et al. EXPERIMENTAL HEMATOLOGY
- Single-cell analysis of mixed-lineage states leading to a binary cell fate choice
- (2016) Andre Olsson et al. NATURE
- The genomic landscape of core-binding factor acute myeloid leukemias
- (2016) Zachary J Faber et al. NATURE GENETICS
- BAP1/ASXL1 recruitment and activation for H2A deubiquitination
- (2016) Danny D. Sahtoe et al. Nature Communications
- ASXL1 plays an important role in erythropoiesis
- (2016) Hui Shi et al. Scientific Reports
- A High-Density Map for Navigating the Human Polycomb Complexome
- (2016) Simon Hauri et al. Cell Reports
- The Role of Additional Sex Combs-Like Proteins in Cancer
- (2016) Jean-Baptiste Micol et al. Cold Spring Harbor Perspectives in Medicine
- Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes
- (2015) D. P. Steensma et al. BLOOD
- Functional proteomics of the epigenetic regulators ASXL1, ASXL2 and ASXL3: a convergence of proteomics and epigenetics for translational medicine
- (2015) Masaru Katoh Expert Review of Proteomics
- The BAP1/ASXL2 Histone H2A Deubiquitinase Complex Regulates Cell Proliferation and Is Disrupted in Cancer
- (2015) Salima Daou et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- UnlikeASXL1andASXL2mutations,ASXL3mutations are rare events in acute myeloid leukemia with t(8;21)
- (2015) Nicolas Duployez et al. LEUKEMIA & LYMPHOMA
- Loss of BAP1 function leads to EZH2-dependent transformation
- (2015) Lindsay M LaFave et al. NATURE MEDICINE
- Role of HOXA9 in leukemia: dysregulation, cofactors and essential targets
- (2015) C T Collins et al. ONCOGENE
- BAP1 promotes breast cancer cell proliferation and metastasis by deubiquitinating KLF5
- (2015) Junying Qin et al. Nature Communications
- Cancer-associated ASXL1 mutations may act as gain-of-function mutations of the ASXL1–BAP1 complex
- (2015) Anand Balasubramani et al. Nature Communications
- Frequent ASXL2 mutations in acute myeloid leukemia patients with t(8;21)/RUNX1-RUNX1T1 chromosomal translocations
- (2014) J.-B. Micol et al. BLOOD
- Variant PRC1 Complex-Dependent H2A Ubiquitylation Drives PRC2 Recruitment and Polycomb Domain Formation
- (2014) Neil P. Blackledge et al. CELL
- SETBP1 mutations drive leukemic transformation in ASXL1-mutated MDS
- (2014) D Inoue et al. LEUKEMIA
- High number of additional genetic lesions in acute myeloid leukemia with t(8;21)/RUNX1-RUNX1T1: frequency and impact on clinical outcome
- (2014) M-T Krauth et al. LEUKEMIA
- Histone H2A monoubiquitination promotes histone H3 methylation in Polycomb repression
- (2014) Reinhard Kalb et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Clonal Hematopoiesis and Blood-Cancer Risk Inferred from Blood DNA Sequence
- (2014) Giulio Genovese et al. NEW ENGLAND JOURNAL OF MEDICINE
- Age-Related Clonal Hematopoiesis Associated with Adverse Outcomes
- (2014) Siddhartha Jaiswal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Stabilization and targeting of INO80 to replication forks by BAP1 during normal DNA synthesis
- (2014) Han-Sae Lee et al. Nature Communications
- Essential role of the IRF8-KLF4 transcription factor cascade in murine monocyte differentiation
- (2013) D. Kurotaki et al. BLOOD
- Loss of Asxl1 leads to myelodysplastic syndrome-like disease in mice
- (2013) J. Wang et al. BLOOD
- Myelodysplastic syndromes are induced by histone methylation–altering ASXL1 mutations
- (2013) Daichi Inoue et al. JOURNAL OF CLINICAL INVESTIGATION
- Prognostic Score Including Gene Mutations in Chronic Myelomonocytic Leukemia
- (2013) Raphaël Itzykson et al. JOURNAL OF CLINICAL ONCOLOGY
- Deletion of Asxl1 results in myelodysplasia and severe developmental defects in vivo
- (2013) Omar Abdel-Wahab et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Mayo prognostic model for WHO-defined chronic myelomonocytic leukemia: ASXL1 and spliceosome component mutations and outcomes
- (2013) M M Patnaik et al. LEUKEMIA
- Mutational landscape and significance across 12 major cancer types
- (2013) Cyriac Kandoth et al. NATURE
- A common ancestry for BAP1 and Uch37 regulators
- (2012) Luis Sanchez-Pulido et al. BIOINFORMATICS
- ASXL1 Mutations Promote Myeloid Transformation through Loss of PRC2-Mediated Gene Repression
- (2012) Omar Abdel-Wahab et al. CANCER CELL
- RYBP-PRC1 Complexes Mediate H2A Ubiquitylation at Polycomb Target Sites Independently of PRC2 and H3K27me3
- (2012) Lígia Tavares et al. CELL
- The HARE-HTH and associated domains
- (2012) L. Aravind et al. CELL CYCLE
- ASXL1 exon 12 mutations are frequent in AML with intermediate risk karyotype and are independently associated with an adverse outcome
- (2012) S Schnittger et al. LEUKEMIA
- PCGF Homologs, CBX Proteins, and RYBP Define Functionally Distinct PRC1 Family Complexes
- (2012) Zhonghua Gao et al. MOLECULAR CELL
- BAP1 loss defines a new class of renal cell carcinoma
- (2012) Samuel Peña-Llopis et al. NATURE GENETICS
- Tumours associated with BAP1 mutations
- (2012) Rajmohan Murali et al. PATHOLOGY
- Loss of the Tumor Suppressor BAP1 Causes Myeloid Transformation
- (2012) A. Dey et al. SCIENCE
- ASXL1 mutations identify a high-risk subgroup of older patients with primary cytogenetically normal AML within the ELN Favorable genetic category
- (2011) K. H. Metzeler et al. BLOOD
- Acquired mutations in ASXL1 in acute myeloid leukemia: prevalence and prognostic value
- (2011) M. Pratcorona et al. HAEMATOLOGICA
- Prognostic Significance of ASXL1 Mutations in Patients With Myelodysplastic Syndromes
- (2011) Felicitas Thol et al. JOURNAL OF CLINICAL ONCOLOGY
- Concomitant analysis of EZH2 and ASXL1 mutations in myelofibrosis, chronic myelomonocytic leukemia and blast-phase myeloproliferative neoplasms
- (2011) O Abdel-Wahab et al. LEUKEMIA
- De novo nonsense mutations in ASXL1 cause Bohring-Opitz syndrome
- (2011) Alexander Hoischen et al. NATURE GENETICS
- The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma
- (2011) Matthew Bott et al. NATURE GENETICS
- Germline mutations in BAP1 predispose to melanocytic tumors
- (2011) Thomas Wiesner et al. NATURE GENETICS
- Clinical Effect of Point Mutations in Myelodysplastic Syndromes
- (2011) Rafael Bejar et al. NEW ENGLAND JOURNAL OF MEDICINE
- ASXL1 mutation is associated with poor prognosis and acute transformation in chronic myelomonocytic leukaemia
- (2010) Véronique Gelsi-Boyer et al. BRITISH JOURNAL OF HAEMATOLOGY
- Genetic Analysis of Transforming Events That Convert Chronic Myeloproliferative Neoplasms to Leukemias
- (2010) O. Abdel-Wahab et al. CANCER RESEARCH
- Histone H2A deubiquitinase activity of the Polycomb repressive complex PR-DUB
- (2010) Johanna C. Scheuermann et al. NATURE
- Mutations of ASXL1 gene in myeloproliferative neoplasms
- (2009) N Carbuccia et al. LEUKEMIA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started